T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)
Clinical trial NCT04128319 · TERMINATED
Trial details
- NCT number
- NCT04128319
- Sponsor
- Xenikos
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2020-02-17
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.